Rallybio Corporation

RLYB • NASDAQ • Stock Fundamentals

Rallybio Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen Uden, with a market cap of $92.3M.

Market Cap$92.3M

Employees30.0

CEOStephen Uden

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 1 month agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Rallybio Corporation

Rallybio Corporation (RLYB) has a market capitalization of $92.3M and trades on NASDAQ.

Rallybio Corporation has approximately 30 employees.